Author:
Suehs Carey M.,Bourdin Arnaud
Funder
Teva Pharmaceutical Industries
Roche
Chiesi Farmaceutici
Gilead Sciences
Boehringer Ingelheim
AstraZeneca
Novartis
Actelion Pharmaceuticals
Reference11 articles.
1. Global strategy for asthma management and prevention,2020
2. Oral corticosteroids tapering in severe asthma;Boulet;Am J Respir Crit Care Med,2020
3. High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients;Lacronique;Eur Respir J,1991
4. Long-term methotrexate treatment in corticosteroid-dependent asthma;Mullarkey;Ann Intern Med,1990
5. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma;Nelson;J Allergy Clin Immunol,1999